M2GEN and Discovery Life Sciences Enter into Agreement to Leverage M2GEN`s New Oncology-Focused Bioinformatics Support Services
(WorldNews Business)

TAMPA, Fla., Sept. 25, 2020 /PRNewswire/ -- M2GEN announced today that it has entered into an agreement with Discovery Life Sciences, a global leader in biospecimen solutions, genomic, cell, and immunohistochemistry (IHC) services, to provide M2GEN`s recently launched oncology-focused bioinformatics support services. Under the agreement, M2GEN will provide pipeline analyses for paired tumor/normal and tumor-only somatic mutation identification from Whole Exome Sequencing (WES), and gene expression and fusion detection from tumor RNA Sequencing (RNA-Seq). M2GEN`s bioinformatics analysis pipelines leverage results and...